The efficacy and safety of 4 cycles of tri-weekly nanoparticle albumin-bound paclitaxel (nab-PTX) followed by 4 cycles of FEC (5-fluorouracil, epirubicin, cyclophosphamide) as neoadjuvant chemotherapy for patients with HER2-negative primary breast cancer - A multicenter phase II study (KBCSG-TR1213)